{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:57:16Z","timestamp":1789091836702,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2290,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.bbmt.2008.11.004","type":"journal-article","created":{"date-parts":[[2009,1,10]],"date-time":"2009-01-10T06:11:02Z","timestamp":1231567862000},"page":"101-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Graft-versus-Host disease Prophylaxis with Everolimus and Tacrolimus Is Associated with a High Incidence of Sinusoidal Obstruction Syndrome and Microangiopathy: Results of the EVTAC Trial"],"prefix":"10.1016","volume":"15","author":[{"given":"Uwe","family":"Platzbecker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"von Bonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eray","family":"Goekkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rgen","family":"Radke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Stoehlmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Schetelig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thiede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Ehninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2008.11.004_bib1","series-title":"Hemopoietic Stem Cell Transplantation","first-page":"159","article-title":"Graft-versus-host disease","author":"Platzbecker","year":"2004"},{"key":"10.1016\/j.bbmt.2008.11.004_bib2","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1182\/blood.V100.12.3877","article-title":"Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia","volume":"100","author":"Gratwohl","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.004_bib3","doi-asserted-by":"crossref","unstructured":"Storb R, Deeg HJ, Whitehead J, et\u00a0al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. N Engl J Med. 314:729\u2013735.","DOI":"10.1056\/NEJM198603203141201"},{"key":"10.1016\/j.bbmt.2008.11.004_bib4","first-page":"2062","article-title":"Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors","volume":"96","author":"Nash","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.004_bib5","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1182\/blood.V88.11.4383.4383","article-title":"Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation","volume":"88","author":"Przepiorka","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.004_bib6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00007890-199902270-00001","article-title":"Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation","volume":"67","author":"Bornhauser","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2008.11.004_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbmt.2005.03.006","article-title":"A phase I\/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation","volume":"11","author":"Nash","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.11.004_bib8","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00007890-200004150-00012","article-title":"Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey","volume":"69","author":"Qi","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2008.11.004_bib9","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/01.TP.0000120391.42712.E8","article-title":"Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood","volume":"77","author":"Barten","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2008.11.004_bib10","doi-asserted-by":"crossref","first-page":"201S","DOI":"10.1016\/S0041-1345(03)00231-8","article-title":"Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation","volume":"35","author":"MacDonald","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2008.11.004_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbmt.2003.12.305","article-title":"Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation","volume":"10","author":"Cutler","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.11.004_bib12","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1182\/blood-2003-02-0489","article-title":"Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation","volume":"102","author":"Antin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.004_bib13","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood-2006-09-046219","article-title":"Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation","volume":"109","author":"Cutler","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.004_bib14","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.transproceed.2007.09.008","article-title":"Proliferation signal inhibitors in transplantation: Questions at the cutting edge of everolimus therapy","volume":"39","author":"Chapman","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2008.11.004_bib15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2008.11.004_bib16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2141.2005.05360.x","article-title":"Activity of sirolimus in patients with myelodysplastic syndrome: results of a pilot study","volume":"128","author":"Platzbecker","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2008.11.004_bib17","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood-2004-06-2494","article-title":"Antileukemic activity of rapamycin in acute myeloid leukemia","volume":"105","author":"Recher","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.004_bib18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/cncr.20026","article-title":"Mammalian target of rapamycin inhibition as therapy for hematologic malignancies","volume":"100","author":"Panwalkar","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2008.11.004_bib19","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood-2002-11-3429","article-title":"Survival of acute myeloid leukemia cells requires PI3 kinase activation","volume":"102","author":"Xu","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.004_bib20","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.transproceed.2006.10.092","article-title":"Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus","volume":"38","author":"Kovarik","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2008.11.004_bib21","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1038\/sj.leu.2404399","article-title":"Association with the single-nucleotide polymorphism (Glu785Lys) of the granulocyte colony-stimulating factor receptor with myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia","volume":"20","author":"Platzbecker","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2008.11.004_bib22","first-page":"S34","article-title":"Pharmacogenetics of liver toxicity in patients receiving allogeneic haematopoietic stem cell transplantation","volume":"37","author":"Goekkurt","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.11.004_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/clinchem\/47.2.348","article-title":"Detection of MboII polymorphism at the 5' promoter region of CYP3A4","volume":"47","author":"Cavalli","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.bbmt.2008.11.004_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2008.11.004_bib25","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M","article-title":"Non-parametric inference for cumulative incidence functions in competing risks studies","volume":"16","author":"Lin","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.bbmt.2008.11.004_bib26","first-page":"825","article-title":"1994 Consensus Conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.11.004_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2008.11.004_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1537-2995.2001.41020184.x","article-title":"Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs","volume":"41","author":"Platzbecker","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2008.11.004_bib29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","article-title":"Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?","volume":"40","author":"Batts","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.11.004_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2141.2005.05458.x","article-title":"Prognostic relevance of \u201cearly-onset\u201d graft-versus-host disease following non-myeloablative haematopoietic cell transplantation","volume":"129","author":"Mielcarek","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2008.11.004_bib31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.bmt.1704831","article-title":"Targeting once-daily intravenous busulfan in combination with fludarabine before allogeneic hematopoietic cell transplantation","volume":"35","author":"Jenke","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.11.004_bib32","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2002-11-3567","article-title":"Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells","volume":"102","author":"Bornhauser","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.004_bib33","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1182\/blood.V100.1.334","article-title":"Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide","volume":"100","author":"Eissner","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.004_bib34","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.bmt.1704930","article-title":"Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity","volume":"35","author":"Eissner","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.11.004_bib35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","article-title":"Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation","volume":"10","author":"Chalandon","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.11.004_bib36","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2003-11-3778","article-title":"Glutathione S-transferase M1 polymorphism: a risk factor for hepatic veno-occlusive disease in bone marrow transplantation","volume":"104","author":"Srivastava","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.004_bib37","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/TP.0b013e318166927b","article-title":"Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness","volume":"85","author":"Chan","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2008.11.004_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1634\/stemcells.2005-0062","article-title":"Mammalian target of rapamycin is required for thrombopoietin-induced proliferation of megakaryocyte progenitors","volume":"24","author":"Drayer","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbmt.2008.11.004_bib39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bmt.1705899","article-title":"Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies","volume":"41","author":"Ho","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.11.004_bib40","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2005.05.694","article-title":"Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older","author":"Wallen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.11.004_bib41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2008.11.004_bib42","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2004-09-3540","article-title":"Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF","volume":"105","author":"Guba","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.11.004_bib43","first-page":"S7","article-title":"Sirolimus is associated with veno-occlusive disease of the liver after myeloablative transplantation","volume":"41","author":"Cutler","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.11.004_bib44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/01.TP.0000136256.56873.41","article-title":"Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives","volume":"78","author":"Anglicheau","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2008.11.004_bib45","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1021\/jm010079y","article-title":"Metabolism of sirolimus and its derivative everolimus by cytochrome P450 3A4: insights from docking, molecular dynamics, and quantum chemical calculations","volume":"44","author":"Kuhn","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.bbmt.2008.11.004_bib46","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbmt.2008.02.009","article-title":"Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors","volume":"14","author":"Furlong","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.11.004_bib47","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1097\/00007890-200112270-00010","article-title":"Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease","volume":"72","author":"Benito","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2008.11.004_bib48","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108004849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108004849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:32:42Z","timestamp":1761057162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879108004849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1083879108004849"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.11.004","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Graft-versus-Host disease Prophylaxis with Everolimus and Tacrolimus Is Associated with a High Incidence of Sinusoidal Obstruction Syndrome and Microangiopathy: Results of the EVTAC Trial","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}